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Abstract
Background: The utilization of post-operative clinical pathways leads to shorter hospital stays and
decreased healthcare costs. This study evaluated patient outcomes after implementation of a 6-day
discharge pathway after a pancreaticoduodenectomy.
Methods: A post-operative clinical pathway was developed and implemented for patients undergoing a
pancreaticoduodenectomy at the present institution aimed at discharge by post-operative day six. Patient
charts were retrospectively reviewed to determine the rates of adherence to the pathway at each step,
readmission and post-operative complications.
Results: In total, 113 consecutive patients underwent a pancreaticoduodenectomy, receiving post-
operative care under the clinical pathway guidelines. The median length of stay was 7 days (mode 6 days);
41% of patients were discharged by post-operative day six, 62% by day seven and 79% by day eight.
In univariate analysis, delayed gastric emptying was associated with a delayed discharge after post-
operative day six (P = 0.002). There were no post-operative deaths and 16% of patients required
readmission within 30 days of discharge. In univariate analysis, obesity was the only variable associated
with an increased rate of readmission (P < 0.001).
Discussion: Clinical pathway utilization after a pancreaticoduodenectomy allows a high percentage of
patients to be discharged within a week and is associated with a low rate of readmission. Clinical pathway
implementation allows for safe and efficient patient care.
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Introduction
A systemized approach to medicine, with the use of checklists,
protocols and algorithms, provides a standardized basis for care,
with improved efficiency and a reduction in errors.1 Such an
approach has been utilized in various surgical fields to improve
the efficiency of post-operative recovery. So-called ‘fast-
track’ recovery has been shown to decrease hospital length of
stay without increasing complications after various surgical
procedures.2–4
A pancreaticoduodenectomy, since its inception and refine-
ment by Whipple and colleagues in 1935, has historically been
associated with high peri-operative morbidity and mortality. Even
by the 1960s and 1970s, hospital mortality was roughly 25%.5
Surgical specialization and the emergence of high volume tertiary
care centres paved the way for a great reduction in the peri-
operative risk of a pancreaticoduodenectomy. In the most recent
decade, peri-operative mortality at many tertiary care centres has
decreased to 1–2%.6 Morbidity has followed a similar trend, but
still remains high after a pancreaticoduodenectomy. Grobmyer
et al. compiled outcomes data from 11 series totalling 2630
patients; in the 1990s, morbidity ranged from 27–47% and hos-
pital length of stay ranged from 12–15 days.7
The application of a ‘fast-track’ recovery after pancreatic
surgery has been shown to further decrease the hospital length of
stay without jeopardizing morbidity or mortality. Montiel Casado
et al. demonstrated that instituting a post-operative pathway
This manuscript was presented at the annual AHPBA meeting, Miami, 7–11
March 2012.
DOI:10.1111/hpb.12016 HPB
HPB 2013, 15, 668–673 © 2012 International Hepato-Pancreato-Biliary Association
reduced the hospital length of stay at their centre to a median total
stay of 11 days.8 Similarly, Berberat et al. reported a reduced hos-
pital length of stay from 14–16 days to a median of 10 days after
implementing three main fast-track parameters: early return to a
normal ward, early return of gastrointestinal function and early
ambulation. Surgical morbidity and mortality was unchanged.9
Balzano et al. demonstrated a reduced incidence of delayed gastric
emptying after implementing a ‘fast-track’ programme.Morbidity
and mortality did not increase, and hospital length of stay
decreased from a median 15 to 13 days.10
At the present institution, a post-operative clinical pathway for
patients undergoing a pancreaticoduodenectomy aimed at dis-
charge by post-operative day six, with well-defined daily param-
eters and goals was developed. The purpose of this study was to
determine adherence to the clinical pathway and determine
whether an aggressive early discharge pathway was associated with
acceptable readmission and post-operative complication rates.
Methods
Patients, pathway description, and definitions
This study was conducted with approval from the Institutional
Review Board at the University of Virginia, including a waiver for
the need to obtain consent. Patient data from a prospectively
collected database of all patients who underwent a pancreati-
coduodenectomy between September 2005 and September 2011
by a single surgeon (T.W.B.) were retrospectively reviewed.Demo-
graphic, operative and postoperative data were collected for each
patient, including dietary, discharge and readmission data.
All patients underwent a standard pancreaticoduodenectomy.
No pylorus-preserving pancreaticoduodenectomies were per-
formed. Patients with borderline resectable disease as defined by
the MD Anderson criteria11 underwent neoadjuvant chemoradia-
tion and all patients were nutritionally optimized pre-operatively.
Patients routinely underwent epidural catheter placement pre-
operatively to assist with post-operative analgesia. Nasogastric
tubes were placed intra-operatively in all patients and constant
suction continued in the post-operative period. No drains were
left at the time of surgery and no feeding jejunostomy or gastros-
tomy tubes were placed. In the post-operative period, each patient
was placed on a clinical pathway (Fig. 1) aimed at discharge by
post-operative day six. Discharge requirements included tolerance
of a solid diet, pain control with oral analgesia, a return to pre-
operative ambulatory status, attending physician approval and
patient comfort with discharge. Prokinetic agents were used selec-
tively for patients with symptoms of delayed gastric emptying and
patients who were taking those medications pre-operatively. Pan-
creatic enzymes were given in selective cases when post-operative
malabsorption occurred. Patients were routinely monitored after
discharge, including a follow-up visit 3–4 weeks post-operatively
and subsequent follow-up visits as indicated.
In this study, the day of surgery was referred to as post-
operative day (POD) no. 0, with subsequent days listed as POD no.
1, no. 2, etc. The International Study Group definitions for delayed
gastric emptying12 and post-operative pancreatic fistula13 were
used.
Outcomes measures and statistical methods
Primary outcomes were length of hospital stay and rate of
readmission within 30 days. Secondary outcomes included adher-
ence to each step of the pathway and post-operative complica-
tions, which were graded using the Clavien–Dindo grading
system.14 Additionally, a univariate analysis was performed to
assess the relationship between pre- /intra-operative variables and
primary outcomes.
All group comparisons in this study were unpaired. Categorical
variables were compared using either Fischer’s exact or Pearson’s
chi-square tests where appropriate. All categorical variables were
expressed as a percentage of the group of origin, and continuous
variables were expressed by means standard error (SE). All
P-values reported were two-tailed, and statistical significance was
Figure 1 Details of the clinical pathway
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indicated by P-values of < 0.05. GraphPad Prism (version 5) soft-
ware (La Jolla, CA, USA) was used for statistical analyses.
Results
During the study period, 113 consecutive patients underwent a
pancreaticoduodenectomy. All patients underwent a standard
pancreaticoduodenectomy with a 9-cm gastrojejunostomy by a
single surgeon (T.W.B.). The demographic data are shown in
Table 1, including comorbid conditions. Two-thirds of patients
underwent surgery for malignant disease, 38% for pancreatic
adenocarcinoma. One-third of the patients had benign disease at
surgery, the majority of whom had cystic neoplasms (n = 18),
pancreatitis (n = 11) and ampullary adenomas (n = 6). Eleven
patients had borderline resectable disease at the time of diagnosis
and underwent neoadjuvant chemoradiation as per protocol
with subsequent restaging and resection. The mean operative
blood loss was 267 cc and only three patients (2.7%) required a
transfusion.
A primary outcome of this study was adherence to the goal of
discharge by POD no. 6. In all, 40.7% of patients were discharged
by POD no. 6 over the course of the study period. This goal was
increasingly met throughout the study period with 37.9%, 35.7%,
42.9% and 46.4% discharged by POD no. 6 by sequential quartiles
(data not shown). 61.9% and 78.7% of patients were discharged
by POD no. 7 and POD no. 8, respectively. Table 2 shows adher-
ence to themajor dietary and discharge parameters of the pathway
and Fig. 2 graphically depicts the post-operative days of discharge
for every patient in the study. As shown, the NGT was removed by
POD no. 3 in 93.0% of patients; 83.2% of patients tolerated a clear
diet by POD no. 4 and 63.7% of patients tolerated a solid diet by
POD no. 5.
Overall 30-day follow-up was excellent for this study (98.2%).
There were no deaths within 30 days of surgery. Overall morbidity
was 48.7% (55/113 patients). Most of these complications were
Clavien grade I/II (38 patients), the majority of which were
Table 1 Patient demographics and operative characteristics
Total number of patients, n 113
Gender (%)
Male 54
Female 46
Age (years  SE) 63.5  1.1
Body mass index (mean  SE) 26.7  0.5
Comorbidities (%)
Obesity (BMI  30) 24
Diabetes mellitus 32
Gastroesophageal reflux disease 27
Smoker 52
Pre-operative radiation (%) 10
ASA score (mean  SE) 2.5  0.05
Type of pancreaticoduodenectomy (%)
Standard 100
Pylorus-preserving 0
Indication (%)
Pancreatic adenocarcinoma 38
Other carcinoma (ampullary, etc.) 29
Benign disease 33
Operative blood loss (ml  SE) 267  19
Transfusion (%) 2.7
BMI, body mass index; ASA, American Society of Anesthesiologists.
Table 2 Pathway parameters
NGT
Day of NGT removal (POD  SE) 3.0  0.1
NGT Removal by POD no. 3 (%) 93.0
Required reinsertion of NGT (%) 6.2
Dietary parameters
POD tolerating clear diet (POD  SE) 4.9  0.5
Tolerating clear diet by POD no. 4 (%) 83.2
POD tolerating solid diet (POD  SE) 6.5  0.5
Tolerating solid diet by POD no. 5 (%) 63.7
Discharge day (%)
POD no. 5 5.3
POD no. 6 35.4
POD no. 7 21.2
POD no. 8 16.8
POD no. 9–10 6.2
POD no. 10–14 9.7
After POD no. 14 5.3
NGT, nasogastric tube; POD, post-operative day.
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Figure 2 A graph of all patients who underwent a pancreaticoduo-
denectomy during the study period and the post-operative day of
discharge
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wound infections and delayed gastric emptying. Fifteen patients
experienced Clavien grade III complications, consisting mainly of
pancreatic fistulae, abdominal fluid collections and wound infec-
tions requiring radiographic or operative intervention. There were
two Clavien grade IV complications, including a patient who
developed post-operative pneumonia and another who developed
post-operative pancreatitis. The most common complication was
delayed gastric emptying, which occurred in 17.7% of patients,
the vast majority of which were classified as grade A using the
ISGPS definition. 15.9% of patients required readmission to the
hospital within 30 days and the reasons for readmission are
detailed in Table 3. Only one patient required readmission for
dehydration and no patients required readmission for failure to
thrive or delayed gastric emptying. The vast majority of readmis-
sions were because of wound-related or other infectious compli-
cations. Patients discharged by POD no. 6 were less likely to
require readmission than those patients discharged on POD no. 7
or later, but this was not statistically significant.
We next performed univariate analyses to determine which
variables were associated with delayed discharge or readmission
(Table 4). For patients less than 65 years of age, there was a trend
towards discharge by POD no. 6 compared with patients 65 years
or older, but this did not reach statistical significance. Patients
who experienced delayed gastric emptying were significantly more
likely to be discharged after POD no. 6 than those patients without
delayed gastric emptying (P = 0.002). Delayed gastric emptying
had no significant impact on the readmission rate. In our univari-
ate analysis, the only factor significantly associated with increased
Table 3 Post-operative and readmission outcomes
30-day follow-up 98.2
30-day mortality (%) 0.0
Total post-operative morbidity (%) 48.7
Clavian grade I/II 33.6
Clavian grade III 13.3
Clavian grade IV/V 1.8
Delayed gastric emptying (%)
Total 17.7
Grade A 15.9
Grade B 0
Grade C 1.8
30-day readmission rate (%)
Total 15.9 P = 0.49
Patients discharged by POD no. 6 13.0
Patients discharged on or after POD no. 7 17.9
Reasons for readmission, n
Wound-related complications 5
Pancreatic fistula 3
Intra-abdominal abscess 3
Other infectious complications 3
Biliary leak 2
Gastrojejunostomy leak 1
Dehydration 1
Failure to thrive/delayed gastric emptying 0
Terms in bold are taken from the Clavien—Dindo Classification of Surgi-
cal Complications.14
POD, post-operative day.
Table 4 Univariate analyses of factors associated with discharge
and readmission
n (%) P-value
Factors associated with discharge by day 6
Age < 65 years 62 (48.4) 0.07
Age  65 years 51 (31.4)
Pre-operative radiation 11 (27.3) 0.34
No pre-operative radiation 102 (42.2)
Diabetes mellitus 36 (38.9) 0.79
No diabetes mellitus 77 (41.6)
Smoker 59 (40.7) 0.99
Non-smoker 54 (40.7)
Gastroesophageal reflux disease 30 (30) 0.16
No gastroesophageal reflux disease 83 (44.6)
Obesity 27 (33.3) 0.37
Non-obese 86 (43.0)
EBL < 250 cc 58 (37.9) 0.54
EBL  250 cc 55 (43.6)
Diagnosis of cancer 76 (40.8) 0.98
Benign disease 37 (40.5)
Delayed gastric emptying 20 (10) 0.002
No delayed gastric emptying 93 (47.3)
Factors associated with readmission
Age < 65 years 62 (16.1) 0.95
Age  65 years 51 (15.7)
Pre-operative radiation 11 (9.1) 0.51
No pre-operative radiation 102 (16.7)
Diabetes mellitus 36 (11.1) 0.34
No diabetes mellitus 77 (18.2)
Smoker 59 (16.9) 0.76
Non-smoker 54 (14.8)
Gastroesophageal reflux disease 30 (23.3) 0.20
No gastroesophageal reflux disease 83 (13.3)
Obesity 27 (37.0) <0.001
Non-obese 86 (9.3)
EBL < 250 cc 58 (19.0) 0.37
EBL  250 cc 55 (12.7)
Diagnosis of cancer 96 (11.8) 0.09
Benign disease 37 (24.3)
Delayed gastric emptying 20 (15) 0.90
No delayed gastric emptying 93 (16.1)
EBL, estimated blood loss.
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readmission was obesity (P < 0.001). There was a trend towards
increased readmission for patients with benign disease; however,
this did not reach statistical significance (P = 0.09).
Discussion
Clinical pathways have been shown to reduce the length of hospital
stay and decrease healthcare costs in a number of complicated
surgical procedures, including pancreatic surgery.3,4,15 A clinical
pathway has been implemented for patients undergoing a pancrea-
ticoduodenectomy aimed at discharge by POD no. 6. Using this
pathway, we successfully discharged 41% of patients by POD no. 6,
62% by POD no. 7, and 79% by POD no. 8. The median length of
stay in our study was 7 days and the mode was 6 days.While these
data donot demonstrate strict adherence to the goal of discharge by
POD no. 6 in all patients, our median length of stay of 7 days
compares favourably to other published series. Berberat et al. dem-
onstrated a median length of stay of 10 days after implementation
of a ‘fast-track’ pathway for patients undergoing all types of pan-
creatic surgery.9 Balzano et al. reported a decreased median length
of stay from 15 to 13 days for patients undergoing a pancreati-
coduodenectomy after utilization of a ‘fast-track’ pathway.10
Kennedy et al. investigated the effects of a similar pathway to this
one,aimed at discharge byPODno.6 or 7,and reported adecreased
length of stay from13 to 7 days, aswell as a nearly 50% reduction in
healthcare costs.15 In our univariate analyses, delayed gastric emp-
tying was associated with failure to discharge by POD no. 6. There
were trends towards failure of discharge by POD no. 6 for elderly
patients (65 years) andpatientswith a diagnosis of gastroesopha-
geal reflux disease, but neither reached statistical significance.
Our pathway essentially consists of a checklist, with specific
goals for each post-operative day. As expected, with each step of
the pathway, there is a slight decrease in adherence; however,
overall a high percentage of patients are able to remain fully on the
pathway for the duration of the post-operative period. For
patients who successfully remained on the pathway and were dis-
charged by POD no. 6, the rate of readmission to the hospital was
13%, compared with 18% for those discharged on or after POD
no. 7. While this did not meet statistical significance, it does indi-
cate that early discharge is not associated with an increased rate of
readmission and implies that successful discharge by POD no. 6 is
likely not owing to discharging patients before they are ready to
leave the hospital.
When establishing a pathway that advocates for early discharge,
there are two critical issues. First, the pathway must be safe. Our
series demonstrated a 0% 30-day mortality rate and a low rate of
major complications such as an anastomotic leak. Second, the
pathway should be associated with a low rate of readmissions. The
overall rate of readmissions within 30 days in our series was 16%
and was 13% for patients discharged by POD no. 6. This rate
compares favourably to other published series showing overall
readmission rates of 21–59%16–19 and the series by Grewal et al.
reporting a 30-day readmission rate of 15% after a pancreati-
coduodenectomy.20 Data on 90-day readmission rates were not
collected, but Kent et al. demonstrated a low (2%) rate of
readmissions between 31 and 90 days after major pancreatic sur-
gery19 and we believe that the majority of readmissions related to
premature discharge will generally present for readmission within
30 days of discharge. In the present series, the majority of the 18
readmissions were because of infectious complications, predomi-
nantly wound-related (n = 5) or intraabdominal abscess (n = 3)
and anastomotic leaks (3 pancreatic, 2 biliary and 1 gastrojejunos-
tomy). Only one patient was readmitted for dehydration and no
other patients were readmitted for failure to thrive or delayed
gastric emptying. The only variable associated with increased rates
of readmission by univariate analysis in our series was obesity.
An unintended positive consequence of the clinical pathway
that we have observed is that it allows for team building, integrat-
ing multiple healthcare providers, including physicians, nurses,
dieticians, therapists and social workers, all working to achieve a
common goal. While we do not have an objective method for
evaluating this, establishment of a clinical pathway has assigned
each member of the team important and defined roles in the care
of each patient and we believe this increases team morale and
consequently better patient care.
In order for an aggressive discharge pathway to be successful,
several factors are absolutely critical. There must be an effort to
educate each patient on what to expect during the post-operative
period, including a thorough explanation of the steps of the
pathway.Understanding the pathway establishes daily goals for the
patient and likely contributes to patient satisfaction and successful
pathway implementation. At the present institution, patient edu-
cation begins in the clinic pre-operatively and continues in the
pre-operative area on the day of surgery and into the post-
operative period. Educating the clinical team is also critical, par-
ticularly in an academic setting, where the composition of the
healthcare team is constantly in flux.We find that this is best done
through face-to-face orientation as well as written guidelines each
time a newmember joins the team. Finally, and most importantly,
in order for a clinical pathway to be successful, the operation must
be technically sound and associated with a relatively low rate of
complications. Other studies have shown that lower blood loss,
blood transfusion and infectious complications contribute to
lower rates of readmission.16,20 In this study, operative blood loss
was very low and only 2.7% of patients required a blood product
transfusion. The overall complication rate was low, including the
incidence of delayed gastric emptying (18%), compared with
other studies using the ISGPS definition for delayed gastric emp-
tying, with rates of 33–59%.21–23
In summary, clinical pathway utilization after a pancreati-
coduodenectomy allows a high percentage of patients to be dis-
charged within a week of surgery, is associated with safe and
efficient patient care and low rates of readmission. In order to
successfully implement such a pathway, education of the patient
and the healthcare team is critical, as well as meticulous surgery
with low operative blood loss and low rates of post-operative
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complications, including delayed gastric emptying and anasto-
motic leak.
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